Source Facts: Financial Supervisory Service DART / 2024-12-18
Disclosure Type: Sales and Supply Contract
💡 3-Second Summary
Hanwha Aerospace has secured a KRW 709.3B contract with DAPA for the 4th mass production of the K21 Infantry Fighting Vehicle and 21 other items, representing 7.58% of its 2023 revenue.
📊 1. Key Disclosure Details & Major Figures
- Contract Category & Title: Goods Supply / K21 Infantry Fighting Vehicle 4th Mass Production and 21 Other Items
- Contract Value: KRW 709,290,211,760 (approx. KRW 709.29B)
- Ratio to Recent Revenue: 7.58% (compared to 2023 consolidated revenue of KRW 9,359,005,981,309)
- Counterparty: Defense Acquisition Program Administration (DAPA)
- Supply Region: Republic of Korea
- Contract Period: December 17, 2024 – September 15, 2028
- Key Terms: Advance payments included / Payment due within 5 days (excluding holidays and Saturdays) after completion, inspection, and invoice submission
- Contract Date: December 17, 2024
📈 2. Expert Perspective: What This Disclosure Means for Investors
This disclosure confirms a major defense supply contract between Hanwha Aerospace and DAPA for the 4th mass production run of K21 Infantry Fighting Vehicles alongside 21 additional items. The total contract value of approximately KRW 709.3B represents 7.58% of the company’s 2023 consolidated annual revenue.
With a execution window spanning nearly four years (ending September 2028), the agreement supports multi-year revenue visibility for the land systems division. Investors can observe project milestones, inspection pass rates, and potential contract amendments over the execution timeline.
📝 Editor’s Comment (by K-STOCK Editor)
Hanwha Aerospace has formalized a KRW 709.3B production agreement with DAPA, solidifying manufacturing volume for the K21 Infantry Fighting Vehicle 4th mass production program.
Moving forward, key observation points include tracking execution progress toward the September 2028 completion date and monitoring cash flow realization following inspection approvals. Investors may also track future filings for any adjustments to contract values or schedule terms.
📢 Disclaimer & Source Notice
Source: This content was structured and newly compiled based on official data submitted to the Financial Supervisory Service’s DART system.
Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
